1.Two cases of lupus cystitis and literature review.
Yisha LI ; Hui LUO ; Yanli XIE ; Xiaoxia ZUO
Journal of Central South University(Medical Sciences) 2011;36(8):813-816
OBJECTIVE:
To improve the understanding of lupus cystitis.
METHODS:
Clinical manifestations, laboratory Results , and image information of 2 cases of lupus cystitis were analysed retrospectively, and another 6 cases in the literature were reviewed.
RESULTS:
Two patients were female. The urinary symptoms followed the gastrointestinal symptoms. Ureterectasia and hydronephrosis were detected in both patients, and intestinal pseudo-obstruction was detected in one patient. In the 6 cases from the literature, ureterectasia and hydronephrosis were detected in all patients, and intestinal pseudo-obstruction was detected in 4.
CONCLUSION
The possibility of lupus cystitis should be considered when lupus patients complain of urinary or bowel symptoms. Glucocorticoid and immunodepressant are effective for lupus cystitis.
Adolescent
;
Adult
;
Cystitis
;
complications
;
diagnosis
;
Female
;
Humans
;
Hydronephrosis
;
etiology
;
Lupus Erythematosus, Systemic
;
complications
;
diagnosis
;
Ureter
;
pathology
2.Calcification of bilateral ureters: a novel association with systemic lupus erythematosus.
De-Xun JIANG ; Yong LIAO ; Yun-Jing BAI
Chinese Medical Journal 2012;125(12):2235-2237
A 16-year-old female patient with systemic lupus erythematosus (SLE) presented with abdominal pain and oliguria, after one month of hospital treatment with methylprednisolone and cyclophosphamide. Computed tomography of the abdomen revealed the calcification of bilateral superior segmental ureteral wall. Computed tomography urography revealed stenosis of bilateral ureters. This calcification may be associated with lupus-induced inflammatory reaction of ureteral endomembrane. By receiving the ureteral catheters, her abdominal pain and oliguria had been completely resolved. After discharge, she underwent the surgery of cutaneous ureterostomy in the local hospital. During two years follow-up, her condition is stable without any symptom of the urinary system.
Adolescent
;
Calcinosis
;
diagnosis
;
etiology
;
Female
;
Humans
;
Lupus Erythematosus, Systemic
;
complications
;
Ureter
;
pathology
3.Systemic Lupus Erythematosus Associated with Familial Moyamoya Disease.
Chang Min LEE ; Sang Yeob LEE ; Seung Hoon RYU ; Sung Won LEE ; Kyung Won PARK ; Won Tae CHUNG
The Korean Journal of Internal Medicine 2003;18(4):244-247
We report on a 13-year-old female with systemic lupus erythematosus (SLE) who exhibited symptoms of severe migraine and familial moyamoya disease. Cerebral magnetic resonance angiography (MRA) showed stenosis and occlusion of the bilateral internal carotid arteries associated with the development of collateral circulation (moyamoya vessels). In a child, as in this case, headaches with cerebral infarction associated with moyamoya disease are unusual. Few cases of SLE associated with familial moyamoya disease have been reported, with no previous reports of such cases from Korea. There were no evidences of antiphospholipid syndrome, and activity of SLE or other risk factors for cerebral occlusion were also absent.
Adolescent
;
Carotid Artery, Internal/pathology
;
Female
;
Human
;
Lupus Erythematosus, Systemic/*complications
;
Magnetic Resonance Angiography
;
Migraine/etiology
;
Moyamoya Disease/*diagnosis/*genetics
5.Angioedema and systemic lupus erythematosus--a complementary association?
Manjari LAHIRI ; Anita Y N LIM
Annals of the Academy of Medicine, Singapore 2007;36(2):142-145
INTRODUCTIONWe report angioedema as a rare presentation leading to a diagnosis of systemic lupus erythematosus (SLE).
CLINICAL PICTUREA diagnosis of angioedema was delayed in a patient presenting with limb and facial swelling until she developed acute upper airway compromise. After excluding allergic and hereditary angioedema, acquired angioedema (AAE) was suspected, possibly precipitated by respiratory tract infection. Associated clinical and laboratory features led to a diagnosis of SLE.
TREATMENTManagement proved challenging and included high dose steroids and immunosuppressants.
OUTCOMEThe patient responded to treatment and remains in remission without recurrence of the angioedema.
CONCLUSIONAAE occurs due to the acquired deficiency of inhibitor of C1 component of complement (C1 INH). Lymphoproliferative disorders and anti-C1 INH antibodies are well-described associations. However, one should also consider the possibility of SLE.
Angioedema ; blood ; etiology ; physiopathology ; therapy ; Antiphospholipid Syndrome ; diagnosis ; etiology ; Brain ; pathology ; Complement C1 Inactivator Proteins ; analysis ; deficiency ; Female ; Humans ; Lupus Erythematosus, Systemic ; complications ; diagnosis ; etiology ; Magnetic Resonance Imaging ; Middle Aged ; Respiration, Artificial ; Respiratory Insufficiency ; etiology ; therapy
6.Hypocomplementemic Urticarial Vasculitis in Systemic Lupus Erythematosus.
Min Young HER ; Joo Yeon SONG ; Dong Yook KIM
Journal of Korean Medical Science 2009;24(1):184-186
Urticarial vasculitis is characterized clinically by urticarial skin lesions and histologically by leukocytoclastic vasculitis. Hypocomplementemic urticarial vasculitis is associated with connective tissue diseases such as systemic lupus erythematosus (SLE). We report a case of urticarial vasculitis that preceded manifestations of SLE.
Anti-Infective Agents/therapeutic use
;
Anti-Inflammatory Agents/therapeutic use
;
Diagnosis, Differential
;
Female
;
Humans
;
Lupus Erythematosus, Systemic/*diagnosis/etiology/pathology
;
Middle Aged
;
Recurrence
;
Skin/pathology
;
Urticaria/complications/*diagnosis
;
Vasculitis, Hypersensitivity/complications/*diagnosis/pathology
7.Two Cases of Refractory Thrombocytopenia in Systemic Lupus Erythematosus that Responded to Intravenous Low-Dose Cyclophosphamide.
Hee Jin PARK ; Mi Il KANG ; Yoon KANG ; Soo Jin CHUNG ; Sang Won LEE ; Yong Beom PARK ; Soo Kon LEE
Journal of Korean Medical Science 2013;28(3):472-475
Treatment of thrombocytopenia in systemic lupus erythematosus (SLE) is considered in cases of current bleeding, severe bruising, or a platelet count below 50,000/microliter. Corticosteroid is the first choice of medication for inducing remission, and immunosuppressive agents can be added when thrombocytopenia is refractory to corticosteroid or recurs despite it. We presented two SLE patients with thrombocytopenia who successfully induced remission after intravenous administration of low-dose cyclophosphamide (CYC) (500 mg fixed dose, biweekly for 3 months), followed by azathioprine (AZA) or mycophenolate mofetil (MMF). Both patients developed severe thrombocytopenia in SLE that did not respond to pulsed methylprednisolone therapy, and started the intravenous low-dose CYC therapy. In case 1, the platelet count increased to 50,000/microliter after the first CYC infusion, and remission was maintained with low dose prednisolone and AZA. The case 2 achieved remission after three cycles of CYC, and the remission continued with low dose prednisolone and MMF.
Azathioprine/therapeutic use
;
Bone Marrow/pathology
;
Cyclophosphamide/*therapeutic use
;
Drug Therapy, Combination
;
Female
;
Humans
;
Immunosuppressive Agents/*therapeutic use
;
Infusions, Intravenous
;
Lupus Erythematosus, Systemic/complications/*diagnosis
;
Middle Aged
;
Mycophenolic Acid/analogs & derivatives/therapeutic use
;
Platelet Count
;
Thrombocytopenia/*diagnosis/*drug therapy/etiology
;
Young Adult